About me
I lead humanitarian medicine donation programs at Sanofi, working at the intersection of access, health systems, and patient-centered design—primarily in hemophilia and rare diseases. My focus is on moving from episodic aid to sustained, system-integrated access to care in low- and middle-income countries.
I’m also the author of Reframing Pharma Through Global Health and Social Science: Evidence Ecologies, where I explore how traditional evidence paradigms often fail to capture real-world complexity—and how “evidence ecologies” can better align scientific rigor with equitable access, uptake, and sustained impact.
What should people talk to me about?
- Designing sustainable donation and access programs (beyond “one-and-done” models)
- Last-mile challenges in humanitarian supply chains and regulatory navigation
- Rethinking evidence paradigms—how we define, generate, and use evidence in global health
- Applying evidence ecologies to bridge clinical data, lived experience, and system realities
- Measuring impact—especially access, equity, and patient-level outcomes
- Partnerships between industry, NGOs, and local health systems
- Why access still fails—even when treatments, funding, and partnerships exist
